about
The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?Binge drinking: Burden of liver disease and beyondClinical significance of donor-specific human leukocyte antigen antibodies in liver transplantationThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseEpidemiology of intrafamilial inflammatory bowel disease throughout EuropeImaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseTreatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.Solitary fibrous tumor arising from the mesentery of adult patients. Report of two cases and review of the literature.High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.Hepatic p63 regulates steatosis via IKKβ/ER stressAssessment of health sciences and science and technology librarian e-science educational needs to develop an e-science web portal for librariansInvolvement of neuron-derived orphan receptor-1 (NOR-1) in LDL-induced mitogenic stimulus in vascular smooth muscle cells: role of CREB.NOR-1 is involved in VEGF-induced endothelial cell growth.Fibulin-5 is up-regulated by hypoxia in endothelial cells through a hypoxia-inducible factor-1 (HIF-1α)-dependent mechanism.Vitamin D deficiency in chronic liver disease.Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.Colorectal adenomas contain multiple somatic mutations that do not coincide with synchronous adenocarcinoma specimensCirculating endothelial progenitor cells and the risk of vascular events after ischemic stroke.Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.Adiponectin and its receptors in non-alcoholic steatohepatitis.Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival.miR-17 and -20a Target the Neuron-Derived Orphan Receptor-1 (NOR-1) in Vascular Endothelial CellsObesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progressionMicroparticle Shedding from Neural Progenitor Cells and Vascular Compartment Cells Is Increased in Ischemic Stroke.Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.Plasma betatrophin levels in patients with liver cirrhosisA morphological method for ammonia detection in liverEtiologies and outcomes of acute liver failure in a spanish communityIntraepithelial lymphocytes subsets in different forms of celiac diseaseEndothelial progenitor cells in acute ischemic stroke.Long-term survival after liver transplantation for alcoholic liver disease.Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.Gastroenterology, a historical specialty with a great future.Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.Resistance to hepatitis C virus. Implications and therapeutic options.NS5A Resistance: Clinical Implications and Treatment Possibilities.Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection.Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort.Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.Serum Levels of Interleukin-34 During Acute Rejection in Liver Transplantation.
P50
Q26772999-10881D97-DCF8-4E08-833A-EEF03B0C0AC0Q26773691-6B195608-601B-4286-813C-7BC4D1BD2A55Q26780271-24C6B2A4-1DB1-4F40-878A-1F1C8A84F0D2Q26780509-B622410E-F8BF-474E-B4DB-B85BD98F34AAQ26999295-50024D0B-784C-463B-84E1-7061B3F17ECEQ30376231-D0D8A44E-EED0-4F40-9EB2-9A1E53CF892FQ31160142-96590BD2-E5C0-4287-80F7-A1651D34D89DQ33414512-E3A5443B-EEED-43A1-AA8F-74FD1356405CQ33423171-D1B02B3D-1245-4CE8-8377-661EDD46223FQ33654494-B459B45C-3EEF-4C12-B7AD-C5319E830858Q33862418-41F68C58-ADD4-4A48-8789-40F1C14D82C1Q34298652-CA78F5EA-9578-4679-8043-3D266D3D014EQ34425570-C619E66B-A443-4E26-9B97-D0E5BEE222DBQ34606161-8B816A37-6613-4820-BC39-1D89234F2CF2Q34728285-41DC5A4A-587C-4C73-A92E-568BD3CCEEC9Q34835301-1A88EDA6-F8D5-4159-9D3D-CBE75B5CF3EEQ35180651-01600D49-016E-48ED-AB40-4962AD1A5542Q35390385-5824E3B8-2F6E-4178-BC64-7A1A4C77ABBEQ35591160-DCE90A67-4F90-42E9-8037-122898BE9507Q35597147-C8B2ADDC-5084-46B3-85B5-CA06270A747FQ35780838-335F4BA8-4F5C-4D59-B082-C20E1092B021Q35850585-31A3EABD-D999-42F0-8B40-854D94BA1B60Q35874842-B0E5D0BA-4290-4117-9A9F-80A828B69AF8Q35905659-AA48CE95-B858-4289-A6C2-B7F0A5665058Q36096369-C29AE458-2C6C-4120-B210-E99A765DC34EQ36105642-28DA8E90-C29C-4547-84B6-26F2BC0DED43Q36314745-35D84F50-189A-435C-96DB-BE208C788D54Q37139673-5EA540B5-F77D-424F-9C03-EB54C404D4A3Q37280319-09393209-2FBB-4C38-9B46-83F6673B6AF3Q37403696-8749E22A-5DEA-44C6-9A76-0476FA1F3956Q37439878-A6071E08-306C-4DEE-A284-72B527F7054FQ37465565-761FC4C4-F995-4AB8-88F2-46D52C111953Q38647018-F166CD76-F49E-4437-A4B3-F47327A1F07AQ38710187-3CC3CD2C-CEBB-45E4-9D46-487C3A5C9C32Q38710778-FDC29BAA-5548-4054-9FE8-35C8D05518A0Q38780200-EF21187C-5824-455A-8A84-93B611021D2DQ38941218-0B12589D-F3FE-4A31-8916-DD0F53B8B166Q38965567-9660D0B0-9AE0-4FF5-9080-15B41EB13D46Q39049269-26D6755F-FEB4-4FBD-B7DD-A5924C46134DQ39118363-2B895687-6DEB-4C0B-80B4-EC0C8D8C0F58
P50
description
researcher ORCID ID = 0000-0001-8248-0172
@en
wetenschapper
@nl
name
Javier Crespo
@ast
Javier Crespo
@en
Javier Crespo
@es
Javier Crespo
@nl
type
label
Javier Crespo
@ast
Javier Crespo
@en
Javier Crespo
@es
Javier Crespo
@nl
prefLabel
Javier Crespo
@ast
Javier Crespo
@en
Javier Crespo
@es
Javier Crespo
@nl
P106
P21
P31
P496
0000-0001-8248-0172